These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34794200)

  • 1. Pathophysiology of Antiphospholipid Syndrome.
    Green D
    Thromb Haemost; 2022 Jul; 122(7):1085-1095. PubMed ID: 34794200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies.
    Galli M; Finazzi G; Bevers EM; Barbui T
    Blood; 1995 Jul; 86(2):617-23. PubMed ID: 7605991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies: specificity and pathophysiology.
    de Groot PG; Oosting JD; Derksen RH
    Baillieres Clin Haematol; 1993 Sep; 6(3):691-709. PubMed ID: 8025348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus anticoagulant antibodies: recognition of phospholipid-binding protein complexes.
    Rauch J
    Lupus; 1998; 7 Suppl 2():S29-31. PubMed ID: 9814668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?
    Oosting JD; Derksen RH; Bobbink IW; Hackeng TM; Bouma BN; de Groot PG
    Blood; 1993 May; 81(10):2618-25. PubMed ID: 8166780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces.
    Simmelink MJ; Horbach DA; Derksen RH; Meijers JC; Bevers EM; Willems GM; De Groot PG
    Br J Haematol; 2001 Jun; 113(3):621-9. PubMed ID: 11380447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory tests for detection of antiphospholipid antibodies].
    Yasumuro Y; Taki M
    Rinsho Byori; 2001 Mar; Suppl 115():91-102. PubMed ID: 11391941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon.
    Rand JH; Wu XX; Andree HA; Ross JB; Rusinova E; Gascon-Lema MG; Calandri C; Harpel PC
    Blood; 1998 Sep; 92(5):1652-60. PubMed ID: 9716593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunobiology and obstetrical consequences of antiphospholipid antibodies.
    Lockwood CJ; Rand JH
    Obstet Gynecol Surv; 1994 Jun; 49(6):432-41. PubMed ID: 7522311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-phospholipid syndrome: Current opinion on mechanisms involved, laboratory characterization and diagnostic aspects.
    Amiral J; Peyrafitte M; Dunois C; Vissac AM; Seghatchian J
    Transfus Apher Sci; 2017 Aug; 56(4):612-625. PubMed ID: 28803708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-beta2-glycoprotein I and anti-prothrombin antibodies in patients with the 'antiphospholipid' syndrome: immunological specificity and clotting profiles.
    Kandiah DA; Krilis SA
    Lupus; 1998; 7(5):323-32. PubMed ID: 9696136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests.
    Galli M; Barbui T
    Semin Thromb Hemost; 2005 Feb; 31(1):17-24. PubMed ID: 15706471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of antiphospholipid antibodies].
    Atsumi T; Koike T
    Rinsho Byori; 1998 Apr; 46(4):297-302. PubMed ID: 9594618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the fibrinolytic process in a patient with antiphospholipid syndrome.
    Marchi R; Garmendia J; Kanzler D; Fuenmayor J
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):239-45. PubMed ID: 24418942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiphospholipid syndrome].
    Atsumi T; Koike T
    Nihon Rinsho; 1998 Jan; 56(1):215-23. PubMed ID: 9465693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and thrombosis.
    Brighton TA; Chesterman CN
    Baillieres Clin Haematol; 1994 Sep; 7(3):541-57. PubMed ID: 7841600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to phosphatidylserine/prothrombin complex in suspected antiphospholipid syndrome in the absence of antibodies to cardiolipin or Beta-2-glycoprotein I.
    Sanfelippo MJ; Joshi A; Schwartz S; Meister JA; Goldberg JW
    Lupus; 2013 Nov; 22(13):1349-52. PubMed ID: 23989738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.